Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1H-NMR Spectroscopy

(2019) Lorena Lorefice et al.   Neurotherapeutics

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring

(2018) Daniel Stoessel et al.   Frontiers in Human Neuroscience

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

KniMet: a pipeline for the processing of chromatography–mass spectrometry metabolomics data

(2018) Sonia Liggi et al.   Metabolomics

MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis

(2018) Jasmine Chong et al.   NUCLEIC ACIDS RESEARCH

Metabolomic profile of systemic sclerosis patients

(2018) Federica Murgia et al.   Scientific Reports

Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis

(2017) Simone Poddighe et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

(2017) Chai K. Lim et al.   Scientific Reports

The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain

(2016) Lukas Haider et al.   BRAIN

Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression

(2016) Jens O. Watzlawik et al.   CURRENT PHARMACEUTICAL DESIGN

Metabolomics in multiple sclerosis

(2016) Pavan Bhargava et al.   Multiple Sclerosis Journal

Metabolomics in multiple sclerosis

(2016) Pavan Bhargava et al.   Multiple Sclerosis Journal

Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis

(2016) Michael D. Lovelace et al.   Frontiers in Immunology

An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis

(2015) Damiana Pieragostino et al.   Molecular BioSystems

Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis

(2014) SN Reinke et al.   Multiple Sclerosis Journal

A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis

(2014) A. M. Dickens et al.   NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Body fluid biomarkers in multiple sclerosis

(2013) Manuel Comabella et al.   LANCET NEUROLOGY

INF-β1b therapy modulates l-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis

(2012) Ivana Stojanovic et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

(2012) Jianguo Xia et al.   Metabolomics

Modern analytical techniques in metabolomics analysis

(2011) Aihua Zhang et al.   ANALYST

Chemometrics in metabolomics—A review in human disease diagnosis

(2009) Rasmus Madsen et al.   ANALYTICA CHIMICA ACTA

Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity

(2008) R.E. Gonsette   JOURNAL OF THE NEUROLOGICAL SCIENCES

Environmental factors and multiple sclerosis

(2008) George C Ebers   LANCET NEUROLOGY

Cerebrospinal Fluid B Cells Correlate with Early Brain Inflammation in Multiple Sclerosis

(2008) Bettina Kuenz et al.   PLoS One